Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,000
Closed -$192K 2521
2026
Q1
$192K Sell
20,000
-155,405
-89% -$1.88M ﹤0.01% 1047
2025
Q4
$2.15M Buy
175,405
+23,163
+15% +$308K 0.01% 439
2025
Q3
$2.03M Buy
+152,242
New +$2.08M 0.01% 446

Other funds holding CARL

TD Waterhouse Canada's CARL Position: Q2 2026 in Review

TD Waterhouse Canada sold out of Carlsmed (CARL) in Q2 2026, closing a stake of 20,000 shares — an estimated $192K sold.

TD Waterhouse Canada first reported a position in CARL in Q3 2025 and held it in 3 quarters. The position peaked at $2.15M in Q4 2025. 75 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • TD Waterhouse Canada reported no remaining Carlsmed position as of Q2 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 20,000 Carlsmed shares in Q2 2026, an estimated $192K.
  • TD Waterhouse Canada first reported a position in Carlsmed in Q3 2025 and held it in 3 quarters.
  • TD Waterhouse Canada's Carlsmed position peaked at $2.15M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.